539519 — Tavexia Lifecare Income Statement
0.000.00%
- IN₹441.19m
- IN₹465.30m
- IN₹322.49m
Annual income statement for Tavexia Lifecare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 15.4 | 22.1 | 35.5 | 52.6 | 322 |
| Cost of Revenue | |||||
| Gross Profit | 7.44 | 18.9 | 25.2 | 44 | -23 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 15.2 | 14.5 | 20.1 | 24.3 | 379 |
| Operating Profit | 0.23 | 7.59 | 15.4 | 28.3 | -56.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.25 | 7.62 | 15.3 | 31.9 | 1.66 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.186 | 5.53 | 11.9 | 24.9 | 2.12 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.186 | 5.53 | 11.9 | 24.9 | 2.12 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.186 | 5.54 | 11.9 | 24.9 | 2.12 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.003 | 0.036 | 0.052 | 0.109 | 0.006 |